Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Zecotek Photonics Inc ZMSPF

Zecotek Photonics Inc is in the business of research and development of photonics technologies. The company is focused on creating advanced materials and integrated optoelectronic devices for high-resolution medical imaging, optical precision surgery, and biopharmaceutical research. It operates in three divisions which include Imaging systems, Optronics systems, and 3D display systems with labs located in Canada, Korea, Russia, Singapore, and the U.S.A. The company develops products such as scintillation crystals, solid-state, photodetectors, positron emission tomography scanning components, lasers, and 3D display and 3D printing technologies. These products are used in sectors such as healthcare, scientific and industrial.


GREY:ZMSPF - Post by User

Bullboard Posts
Comment by impegaon Dec 17, 2013 3:46pm
113 Views
Post# 22015303

RE:RE:$61 mil. marketcap

RE:RE:$61 mil. marketcapHey bankerboy, Zacks has an in-depth research report which has a $4 target for the stock. The report is very detailed and considers all the factors which you state many investors ignore.

Zacks considers the partnership with Hamamatsu to have tremendous value. Of note, Hamamatsu will handle marketing and distribution of most of Zecotek's imaging products including their LFS crystals and MAPD photo detectors. They will also manufacture the MAPD and IDM products.

In my opinion the partnership agreement with Hamamatsu is the single most important event in Zecotek's history. It in effect assures the future of the company.

A favourable Markman hearing verdict will double or triple the current market cap while a negative outcome will hurt short term but the future is still bright  given the strong prospects generated through the partnership.

So the current share price in my opinion presents a very favourable entry point with all of the upside just ahead. Of course there is risk but there is also amazing reward potential.
 
Bullboard Posts